Search

everythinglearnresearchcommunity

for

Search:↓

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Exosomes could be a promising way to help repair skin and treat skin disorders.

KCNQ potassium channels help control the sensitivity of touch receptors in the skin.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Macrophage-stimulating protein helps hair grow and can start hair growth phase in mice and human hair samples.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The gene Tfap2b is essential for creating a type of stem cell in zebrafish that can become different pigment cells.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

EGFR inhibitors can cause yellowish skin eruptions.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

EGF controls hair growth by regulating hair follicles' growth phases.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.